Allergy Therapeutics (AGY) — Free Cash Flow Generation Index
Allergy Therapeutics (AGY) has a Free Cash Flow Generation Index of 0.69x as of December 2021. Free cash flow of GBX2.56 Million represents 1% of operating cash flow (GBX3.71 Million). See Allergy Therapeutics current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Allergy Therapeutics Free Cash Flow Generation Index (2003–2021)
Historical FCF Generation Index trend for Allergy Therapeutics across 11 annual periods. Explore Allergy Therapeutics debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Allergy Therapeutics (2003–2021)
Year-by-year Free Cash Flow Generation Index for Allergy Therapeutics. For the full company profile including market capitalisation, see Allergy Therapeutics (AGY) total market value.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.70x | GBX5.95 Million | GBX8.52 Million | GBX2.56 Million | ▼ -11.8% |
| 2020 | 0.79x | GBX9.73 Million | GBX12.28 Million | GBX2.55 Million | ▲ +59.1% |
| 2019 | 0.50x | GBX2.79 Million | GBX5.60 Million | GBX2.81 Million | ▲ +106.7% |
| 2017 | -7.43x | GBX-1.32 Million | GBX178.00K | GBX1.50 Million | ▼ -1241.5% |
| 2015 | 0.65x | GBX2.03 Million | GBX3.12 Million | GBX1.09 Million | ▲ +10.9% |
| 2014 | 0.59x | GBX1.27 Million | GBX2.17 Million | GBX898.00K | ▼ -11.4% |
| 2013 | 0.66x | GBX1.61 Million | GBX2.43 Million | GBX821.00K | ▲ +17.8% |
| 2012 | 0.56x | GBX1.62 Million | GBX2.88 Million | GBX1.26 Million | ▲ +23819.6% |
| 2010 | 0.00x | GBX4.00K | GBX1.70 Million | GBX1.70 Million | ▼ -99.6% |
| 2004 | 0.60x | GBX1.15 Million | GBX1.91 Million | GBX760.00K | ▼ -25.4% |
| 2003 | 0.81x | GBX1.69 Million | GBX2.10 Million | GBX406.00K | — |